J9179 Eribulin mesylate injection
J-Codes
Also known as: eribulin, Halaven
Intravenous injection of eribulin mesylate, a microtubule inhibitor derived from halichondrin.
Clinical Context
Used for metastatic breast cancer and liposarcoma, stabilizing microtubule structure.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.